This won't be a long one. The Phillies are almost certainly not going to be bringing back Max Kepler next season, after the free agent played one mediocre year in Philadelphia. "Max Kepler I think did ...

Update: As of 4:30 p.m., the crash has been cleared and the northbound lanes reopened. A crash in York County is closing part of Interstate 83 north Thursday afternoon, according to PennDOT. The crash ...

Add articles to your saved list and come back to them any time. Each year, the toughest HSC maths exam ends in a question notorious for its sheer difficulty, often stumping even the state’s best ...

Kara Greenberg is a senior news editor for Investopedia, where she does work writing, editing, and assigning daily markets and investing news. Prior to joining Investopedia, Kara was a researcher and ...

The electric vehicle industry is struggling to overcome a less favorable political climate. Among the various players, Rivian remains a cheaper alternative to giants like Tesla. However, it is often ...

While OpenAI projects $13 billion in current-year revenue and roughly 3x growth, it remains private and inaccessible to most investors. Palantir, by contrast, is public, generating $4.16 billion in ...

CEO Richard Fairbank emphasized the dominant impact of the Discover acquisition, stating the third quarter reflected "the impact of a full quarter of combined operations, a combined quarter end ...

Thousands across the Triangle on Saturday joined an even bigger number of millions across the nation to protest the Trump Administration in a second round of "No Kings" protests. “I want to be out for ...

[SINGAPORE] Prince Holding Group – accused by the US authorities of running scam compounds in Cambodia – counts several Singaporeans among its top executives, and had previously engaged Temasek-owned ...

New Jersey gubernatorial hopeful Mikie Sherrill bashed President Trump for threatening to “terminate” the long-delayed $16 billion Gateway Tunnel Project under the Hudson River — as Dems refuse to ...

Gilead Sciences' Kite Pharma is doubling down on in vivo CAR-T, this time inking a deal worth up to $1.64 billion biobucks with Chinese biotech Pregene Biopharma. Kite has paid out $120 million ...

NEW JERSEY — The nation’s most critical infrastructure project is in flux following a bombshell declaration by President Donald Trump on Oct. 15. During a press conference with reporters at the White ...